BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 21906423)

  • 1. Recommendations for the use of biologic therapy in rheumatoid arthritis: update from the Italian Society for Rheumatology I. Efficacy.
    Caporali R; Conti F; Alivernini S; Atzeni F; Seriolo B; Cutolo M; Valesini G; Ferraccioli G; Sarzi-Puttini P; Salvarani C; Guiducci S; Zampogna G; Gremese E; Pipitone N; Scrivo R; Bugatti S; Montecucco C; Matucci-Cerinic M;
    Clin Exp Rheumatol; 2011; 29(3 Suppl 66):S7-14. PubMed ID: 21906423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recommendations for the use of biologic therapy in rheumatoid arthritis: update from the Italian Society for Rheumatology II. Safety.
    Favalli EG; Caporali R; Sinigaglia L; Pipitone N; Miniati I; Montecucco C; Matucci-Cerinic M;
    Clin Exp Rheumatol; 2011; 29(3 Suppl 66):S15-27. PubMed ID: 21906424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recommendations for the use of biologic therapy in the treatment of psoriatic arthritis: update from the Italian Society for Rheumatology.
    Salvarani C; Pipitone N; Marchesoni A; Cantini F; Cauli A; Lubrano E; Punzi L; Scarpa R; Spadaro A; Matucci-Cerinic M; Olivieri I;
    Clin Exp Rheumatol; 2011; 29(3 Suppl 66):S28-41. PubMed ID: 21906425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recommendations for the use of biologic therapy from the Italian Society for Rheumatology: off-label use.
    Todoerti M; Pipitone N; Matucci-Cerinic M; Montecucco C; Caporali R;
    Clin Exp Rheumatol; 2011; 29(3 Suppl 66):S42-62. PubMed ID: 21906426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Updating the Italian Society for Rheumatology recommendations for biologic therapy in adult patients with inflammatory rheumatic diseases.
    Montecucco C; Caporali R; Matucci-Cerinic M
    Clin Exp Rheumatol; 2011; 29(3 Suppl 66):S3-6. PubMed ID: 21906422
    [No Abstract]   [Full Text] [Related]  

  • 6. 2016 updated Thai Rheumatism Association Recommendations for the use of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis.
    Louthrenoo W; Kasitanon N; Katchamart W; Aiewruengsurat D; Chevaisrakul P; Chiowchanwisawakit P; Dechanuwong P; Hanvivadhanakul P; Mahakkanukrauh A; Manavathongchai S; Muangchan C; Narongroeknawin P; Phumethum V; Siripaitoon B; Suesuwan A; Suwannaroj S; Uea-Areewongsa P; Ukritchon S; Asavatanabodee P; Koolvisoot A; Nanagara R; Totemchokchyakarn K; Nuntirooj K; Kitumnuaypong T
    Int J Rheum Dis; 2017 Sep; 20(9):1166-1184. PubMed ID: 28730640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2014 update of the Consensus Statement of the Spanish Society of Rheumatology on the use of biological therapies in rheumatoid arthritis.
    Sanmartí R; García-Rodríguez S; Álvaro-Gracia JM; Andreu JL; Balsa A; Cáliz R; Fernández-Nebro A; Ferraz-Amaro I; Gómez-Reino JJ; González-Álvaro I; Martín-Mola E; Martínez-Taboada VM; Ortiz AM; Tornero J; Marsal S; Moreno-Muelas JV
    Reumatol Clin; 2015; 11(5):279-94. PubMed ID: 26051464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MonitorNet: the Italian multi-centre observational study aimed at estimating the risk/benefit profile of biologic agents in real-world rheumatology practice.
    Sfriso P; Salaffi F; Montecucco CM; Bombardieri S; Todesco S
    Reumatismo; 2009; 61(2):132-9. PubMed ID: 19633800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence-based recommendations for the diagnosis and management of rheumatoid arthritis for non-rheumatologists: Integrating systematic literature research and expert opinion of the Thai Rheumatism Association.
    Katchamart W; Narongroeknawin P; Chevaisrakul P; Dechanuwong P; Mahakkanukrauh A; Kasitanon N; Pakchotanon R; Sumethkul K; Ueareewongsa P; Ukritchon S; Bhurihirun T; Duangkum K; Intapiboon P; Intongkam S; Jangsombatsiri W; Jatuworapruk K; Kositpesat N; Leungroongroj P; Lomarat W; Petcharat C; Sittivutworapant S; Suebmee P; Tantayakom P; Tipsing W; Asavatanabodee P; Chiowchanwisawakit P; Foocharoen C; Koolvisoot A; Louthrenoo W; Siripaitoon B; Totemchokchyakarn K; Kitumnuaypong T;
    Int J Rheum Dis; 2017 Sep; 20(9):1142-1165. PubMed ID: 27452207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kuwait association of rheumatology 2018 treatment recommendations for patients with rheumatoid arthritis.
    Alhajeri H; Abutiban F; Al-Adsani W; Al-Awadhi A; Aldei A; AlEnizi A; Alhadhood N; Al-Herz A; Alkandari W; Dehrab A; Muhanna Ghanem AA; Hasan E; Hayat S; Saleh K; Tarakmeh H; Ali Y
    Rheumatol Int; 2019 Sep; 39(9):1483-1497. PubMed ID: 31309293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recommendations for infectious disease screening in migrants to Western Europe with inflammatory arthropathies before starting biologic agents. Results from a multidisciplinary task force of four European societies (SIR, SER, SIMET, SEMTSI) facing the largest impact of the flow of migrants today.
    Bartalesi F; Scirè C; Requena-Méndez A; Abad MA; Buonfrate D; Caporali R; Conti F; Diaz-Gonzalez F; Fernández-Espartero C; Martinez-Fernandez C; Mascarello M; Generali E; Minisola G; Morrone A; Muñoz J; Richi P; Sakellariou G; Salas Coronas J; Spinicci M; Castelli F; Bartoloni A; Bisoffi Z; Gimenez-Sanchez F; Muñoz-Fernandez S; Matucci-Cerinic M
    Clin Exp Rheumatol; 2017; 35(5):752-765. PubMed ID: 28516869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.
    Singh JA; Saag KG; Bridges SL; Akl EA; Bannuru RR; Sullivan MC; Vaysbrot E; McNaughton C; Osani M; Shmerling RH; Curtis JR; Furst DE; Parks D; Kavanaugh A; O'Dell J; King C; Leong A; Matteson EL; Schousboe JT; Drevlow B; Ginsberg S; Grober J; St Clair EW; Tindall E; Miller AS; McAlindon T;
    Arthritis Care Res (Hoboken); 2016 Jan; 68(1):1-25. PubMed ID: 26545825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis.
    Singh JA; Furst DE; Bharat A; Curtis JR; Kavanaugh AF; Kremer JM; Moreland LW; O'Dell J; Winthrop KL; Beukelman T; Bridges SL; Chatham WW; Paulus HE; Suarez-Almazor M; Bombardier C; Dougados M; Khanna D; King CM; Leong AL; Matteson EL; Schousboe JT; Moynihan E; Kolba KS; Jain A; Volkmann ER; Agrawal H; Bae S; Mudano AS; Patkar NM; Saag KG
    Arthritis Care Res (Hoboken); 2012 May; 64(5):625-39. PubMed ID: 22473917
    [No Abstract]   [Full Text] [Related]  

  • 14. The new 2012 German recommendations for treating rheumatoid arthritis : differences compared to the European standpoint.
    Wollenhaupt J; Albrecht K; Krüger K; Müller-Ladner U
    Z Rheumatol; 2013 Feb; 72(1):6-9. PubMed ID: 23392597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.
    Goodman SM; Springer B; Guyatt G; Abdel MP; Dasa V; George M; Gewurz-Singer O; Giles JT; Johnson B; Lee S; Mandl LA; Mont MA; Sculco P; Sporer S; Stryker L; Turgunbaev M; Brause B; Chen AF; Gililland J; Goodman M; Hurley-Rosenblatt A; Kirou K; Losina E; MacKenzie R; Michaud K; Mikuls T; Russell L; Sah A; Miller AS; Singh JA; Yates A
    Arthritis Rheumatol; 2017 Aug; 69(8):1538-1551. PubMed ID: 28620948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. German guidelines for the sequential medical treatment of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs.
    Albrecht K; Krüger K; Wollenhaupt J; Alten R; Backhaus M; Baerwald C; Bolten W; Braun J; Burkhardt H; Burmester GR; Gaubitz M; Gause A; Gromnica-Ihle E; Kellner H; Kuipers J; Krause A; Lorenz HM; Manger B; Nüßlein H; Pott HG; Rubbert-Roth A; Schneider M; Specker C; Schulze-Koops H; Tony HP; Wassenberg S; Müller-Ladner U;
    Rheumatol Int; 2014 Jan; 34(1):1-9. PubMed ID: 23942828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 2008 American College of Rheumatology recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis: where the rubber meets the road.
    Bathon JM; Cohen SB
    Arthritis Rheum; 2008 Jun; 59(6):757-9. PubMed ID: 18512712
    [No Abstract]   [Full Text] [Related]  

  • 18. 2018 update of the APLAR recommendations for treatment of rheumatoid arthritis.
    Lau CS; Chia F; Dans L; Harrison A; Hsieh TY; Jain R; Jung SM; Kishimoto M; Kumar A; Leong KP; Li Z; Lichauco JJ; Louthrenoo W; Luo SF; Mu R; Nash P; Ng CT; Suryana B; Wijaya LK; Yeap SS
    Int J Rheum Dis; 2019 Mar; 22(3):357-375. PubMed ID: 30809944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treating rheumatoid arthritis to target: an Italian rheumatologists' survey on the acceptance of the treat-to-target recommendations.
    Caporali R; Conti F; Covelli M; Govoni M; Salaffi F; Ventriglia G; Montecucco C
    Clin Exp Rheumatol; 2014; 32(4):471-6. PubMed ID: 24960620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update of French society for rheumatology recommendations for managing rheumatoid arthritis.
    Daien C; Hua C; Gaujoux-Viala C; Cantagrel A; Dubremetz M; Dougados M; Fautrel B; Mariette X; Nayral N; Richez C; Saraux A; Thibaud G; Wendling D; Gossec L; Combe B
    Joint Bone Spine; 2019 Mar; 86(2):135-150. PubMed ID: 30315988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.